{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T06:40:42Z","timestamp":1792737642082,"version":"4.5.0"},"reference-count":129,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T00:00:00Z","timestamp":1739145600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004748","name":"Mashhad University of Medical Sciences","doi-asserted-by":"publisher","award":["4001807"],"award-info":[{"award-number":["4001807"]}],"id":[{"id":"10.13039\/501100004748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research Bulletin"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.brainresbull.2025.111256","type":"journal-article","created":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T02:59:37Z","timestamp":1739329177000},"page":"111256","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Exosome-based platforms for treatment of multiple sclerosis"],"prefix":"10.1016","volume":"222","author":[{"given":"Aidin Mohammadi","family":"Zonouz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahboobeh Ghasemzadeh","family":"Rahbardar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6853-8371","authenticated-orcid":false,"given":"Mona","family":"Alibolandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.brainresbull.2025.111256_bib1","article-title":"Insights into exosome transport through the blood-brain barrier and the potential therapeutical applications in brain diseases","volume":"16","author":"Abdelsalam","year":"2023","journal-title":"Pharm. (Basel, Switz. )"},{"issue":"1","key":"10.1016\/j.brainresbull.2025.111256_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15010066","article-title":"Engineered exosomes for tumor-targeted drug delivery: a focus on genetic and chemical functionalization","volume":"15","author":"Akbari","year":"2022","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.brainresbull.2025.111256_bib3","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nbt.1807","article-title":"Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes","volume":"29","author":"Alvarez-Erviti","year":"2011","journal-title":"Nat. Biotechnol."},{"issue":"24","key":"10.1016\/j.brainresbull.2025.111256_bib4","doi-asserted-by":"crossref","first-page":"5722","DOI":"10.3390\/jcm10245722","article-title":"The complement system, T cell response, and cytokine shift in normotensive versus pre-eclamptic and lupus pregnancy","volume":"10","author":"Ancu\u021ba","year":"2021","journal-title":"J. Clin. Med."},{"issue":"10","key":"10.1016\/j.brainresbull.2025.111256_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025721","article-title":"Fabrication principles and their contribution to the superior in vivo therapeutic efficacy of nano-liposomes remote loaded with glucocorticoids","volume":"6","author":"Avnir","year":"2011","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.brainresbull.2025.111256_bib6","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.neuron.2018.01.021","article-title":"Multiple sclerosis: mechanisms and immunotherapy","volume":"97","author":"Baecher-Allan","year":"2018","journal-title":"Neuron"},{"issue":"6","key":"10.1016\/j.brainresbull.2025.111256_bib7","doi-asserted-by":"crossref","DOI":"10.1111\/sji.13013","article-title":"Umbilical cord mesenchymal stem cells as well as their released exosomes suppress proliferation of activated PBMCs in multiple sclerosis","volume":"93","author":"Baharlooi","year":"2021","journal-title":"Scand. J. Immunol."},{"issue":"2","key":"10.1016\/j.brainresbull.2025.111256_bib8","first-page":"389","article-title":"Immunomodulatory potential of human mesenchymal stem cells and their exosomes on multiple sclerosis","volume":"12","author":"Baharlooi","year":"2022","journal-title":"Adv. Pharm. Bull."},{"issue":"9 B","key":"10.1016\/j.brainresbull.2025.111256_bib9","first-page":"1","article-title":"Evaluating risks, costs, and benefits of new and emerging therapies to optimize outcomes in multiple sclerosis","volume":"18","author":"Bandari","year":"2012","journal-title":"J. Manag. Care Pharm."},{"key":"10.1016\/j.brainresbull.2025.111256_bib10","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/cen3.12576","article-title":"Mechanism of demyelination and remyelination in multiple sclerosis","volume":"11","author":"Bando","year":"2020","journal-title":"Clin. Exp. Neuroimmunol."},{"key":"10.1016\/j.brainresbull.2025.111256_bib11","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jconrel.2022.06.011","article-title":"Recent progresses in exosome-based systems for targeted drug delivery to the brain","volume":"348","author":"Bashyal","year":"2022","journal-title":"J. Control. Release"},{"issue":"10","key":"10.1016\/j.brainresbull.2025.111256_bib12","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S1474-4422(20)30277-5","article-title":"Cognitive impairment in multiple sclerosis: clinical management, MRI, and therapeutic avenues","volume":"19","author":"Benedict","year":"2020","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.brainresbull.2025.111256_bib13","article-title":"Advances in imaging strategies for in vivo tracking of exosomes","volume":"12","author":"Betzer","year":"2020","journal-title":"Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnology"},{"issue":"2","key":"10.1016\/j.brainresbull.2025.111256_bib14","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/14737175.2019.1561284","article-title":"Ocrelizumab for the treatment of multiple sclerosis","volume":"19","author":"Bigaut","year":"2019","journal-title":"Expert Rev. Neurother."},{"issue":"6","key":"10.1016\/j.brainresbull.2025.111256_bib15","article-title":"Exosomes as Naturally Occurring Vehicles for Delivery of Biopharmaceuticals: Insights from Drug Delivery to Clinical Perspectives","volume":"11","author":"Butreddy","year":"2021","journal-title":"Nanomater. (Basel, Switz. )"},{"issue":"4","key":"10.1016\/j.brainresbull.2025.111256_bib16","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41577-022-00763-8","article-title":"The roles of extracellular vesicles in the immune system","volume":"23","author":"Buzas","year":"2023","journal-title":"Nat. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.brainresbull.2025.111256_bib17","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1016\/j.ymthe.2018.06.024","article-title":"Extracellular vesicles containing IL-4 modulate neuroinflammation in a mouse model of multiple sclerosis","volume":"26","author":"Casella","year":"2018","journal-title":"Mol. Ther.: J. Am. Soc. Gene Ther."},{"key":"10.1016\/j.brainresbull.2025.111256_bib18","article-title":"Exosomes, a new star for targeted delivery","volume":"9","author":"Chen","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"4","key":"10.1016\/j.brainresbull.2025.111256_bib19","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s13770-021-00361-0","article-title":"Biodistribution of exosomes and engineering strategies for targeted delivery of therapeutic exosomes","volume":"18","author":"Choi","year":"2021","journal-title":"Tissue Eng. Regen. Med."},{"issue":"3","key":"10.1016\/j.brainresbull.2025.111256_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14030672","article-title":"Strategies for targeted delivery of exosomes to the brain: advantages and challenges","volume":"14","author":"Choi","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.brainresbull.2025.111256_bib21","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.cca.2019.10.022","article-title":"Exosomes: current use and future applications","volume":"500","author":"Chung","year":"2020","journal-title":"Clin. Chim. Acta"},{"issue":"12","key":"10.1016\/j.brainresbull.2025.111256_bib22","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.3390\/cells8121497","article-title":"Placental mesenchymal stem cell-derived extracellular vesicles promote myelin regeneration in an animal model of multiple sclerosis","volume":"8","author":"Clark","year":"2019","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.brainresbull.2025.111256_bib23","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/adj.12510","article-title":"Managing the oral side-effects of medications used to treat multiple sclerosis","volume":"62","author":"Cockburn","year":"2017","journal-title":"Aust. Dent. J."},{"issue":"7","key":"10.1016\/j.brainresbull.2025.111256_bib24","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3390\/biomedicines8070227","article-title":"Sphingosine-1-phosphate: its pharmacological regulation and the treatment of multiple sclerosis: a review article","volume":"8","author":"Cohan","year":"2020","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.brainresbull.2025.111256_bib25","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3390\/biomedicines7010014","article-title":"Mechanisms of neurodegeneration and axonal dysfunction in progressive multiple sclerosis","volume":"7","author":"Correale","year":"2019","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.brainresbull.2025.111256_bib26","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41392-020-00261-0","article-title":"Exosomes: key players in cancer and potential therapeutic strategy","volume":"5","author":"Dai","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"issue":"8","key":"10.1016\/j.brainresbull.2025.111256_bib27","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s40263-018-0562-0","article-title":"Cladribine tablets: a review in relapsing MS","volume":"32","author":"Deeks","year":"2018","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.brainresbull.2025.111256_bib28","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/sci3010012","article-title":"Role of peripheral immune cells in multiple sclerosis and experimental autoimmune encephalomyelitis","volume":"3","author":"Dhaiban","year":"2021","journal-title":"Sci"},{"issue":"1","key":"10.1016\/j.brainresbull.2025.111256_bib29","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/s12951-023-01973-5","article-title":"Extracellular vesicles: a rising star for therapeutics and drug delivery","volume":"21","author":"Du","year":"2023","journal-title":"J. Nanobiotechnology"},{"issue":"1","key":"10.1016\/j.brainresbull.2025.111256_bib30","doi-asserted-by":"crossref","first-page":"7473","DOI":"10.1038\/s41598-018-25676-2","article-title":"Nanovesicles from adipose-derived mesenchymal stem cells inhibit T lymphocyte trafficking and ameliorate chronic experimental autoimmune encephalomyelitis","volume":"8","author":"Farinazzo","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.brainresbull.2025.111256_bib31","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jconrel.2016.02.037","article-title":"Exosomes as therapeutics: the implications of molecular composition and exosomal heterogeneity","volume":"228","author":"Ferguson","year":"2016","journal-title":"J. Control. Release"},{"issue":"6","key":"10.1016\/j.brainresbull.2025.111256_bib32","article-title":"Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysis","author":"Filippini","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"issue":"5-6","key":"10.1016\/j.brainresbull.2025.111256_bib33","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1159\/000357427","article-title":"Nabiximols (THC\/CBD oromucosal spray, Sativex\u00ae) in clinical practice-results of a multicenter, non-interventional study (MOVE 2) in patients with multiple sclerosis spasticity","volume":"71","author":"Flachenecker","year":"2014","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.brainresbull.2025.111256_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.impact.2020.100261","article-title":"Exosome engineering: current progress in cargo loading and targeted delivery","volume":"20","author":"Fu","year":"2020","journal-title":"NanoImpact"},{"issue":"1","key":"10.1016\/j.brainresbull.2025.111256_bib35","article-title":"Current perspectives on in vivo noninvasive tracking of extracellular vesicles with molecular imaging","volume":"2017","author":"Gangadaran","year":"2017","journal-title":"BioMed. Res. Int."},{"issue":"5","key":"10.1016\/j.brainresbull.2025.111256_bib36","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3109\/1547691X.2016.1159264","article-title":"Application of nanomedicine for crossing the blood\u2013brain barrier: theranostic opportunities in multiple sclerosis","volume":"13","author":"Ghalamfarsa","year":"2016","journal-title":"J. Immunotoxicol."},{"issue":"3","key":"10.1016\/j.brainresbull.2025.111256_bib37","doi-asserted-by":"crossref","first-page":"505","DOI":"10.34172\/apb.2021.058","article-title":"Prophylactic and therapeutic effects of MOG-Conjugated PLGA nanoparticles in C57Bl\/6 mouse model of multiple sclerosis","volume":"11","author":"Gholamzad","year":"2021","journal-title":"Adv. Pharm. Bull."},{"key":"10.1016\/j.brainresbull.2025.111256_bib38","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/cen3.12261","article-title":"The pathogenesis of multiple sclerosis","volume":"6","author":"Goodin","year":"2015","journal-title":"Clin. Exp. Neuroimmunol."},{"issue":"4","key":"10.1016\/j.brainresbull.2025.111256_bib39","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.apsb.2016.02.001","article-title":"Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges","volume":"6","author":"Ha","year":"2016","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.brainresbull.2025.111256_bib40","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s12943-022-01671-0","article-title":"Exosome biogenesis: machinery, regulation, and therapeutic implications in cancer","volume":"21","author":"Han","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.brainresbull.2025.111256_bib41","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jconrel.2015.03.033","article-title":"Exosomes as drug delivery vehicles for Parkinson's disease therapy","volume":"207","author":"Haney","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.brainresbull.2025.111256_bib42","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s11481-019-09884-9","article-title":"Macrophage-derived extracellular vesicles as drug delivery systems for triple negative breast cancer (TNBC) therapy","volume":"15","author":"Haney","year":"2020","journal-title":"J. neuroimmune Pharmacol."},{"issue":"12","key":"10.1016\/j.brainresbull.2025.111256_bib43","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.amjmed.2020.05.049","article-title":"Treatment of multiple sclerosis: a review","volume":"133","author":"Hauser","year":"2020","journal-title":"Am. J. Med."},{"issue":"10","key":"10.1016\/j.brainresbull.2025.111256_bib44","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1007\/s13346-021-01087-1","article-title":"Exosomal targeting and its potential clinical application","volume":"12","author":"He","year":"2022","journal-title":"Drug Deliv. Transl. Res."},{"issue":"4","key":"10.1016\/j.brainresbull.2025.111256_bib45","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.tips.2021.01.004","article-title":"Emerging therapeutic applications for fumarates","volume":"42","author":"Hoogendoorn","year":"2021","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.brainresbull.2025.111256_bib46","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jconrel.2019.02.032","article-title":"Immunomodulatory properties of MSC-derived exosomes armed with high affinity aptamer toward mylein as a platform for reducing multiple sclerosis clinical score","volume":"299","author":"Hosseini Shamili","year":"2019","journal-title":"J. Control. Release: Off. J. Control. Release Soc."},{"issue":"46","key":"10.1016\/j.brainresbull.2025.111256_bib47","doi-asserted-by":"crossref","first-page":"43374","DOI":"10.1021\/acsomega.3c04479","article-title":"Research advances of engineered exosomes as drug delivery carrier","volume":"8","author":"Huang","year":"2023","journal-title":"ACS Omega"},{"issue":"6","key":"10.1016\/j.brainresbull.2025.111256_bib48","doi-asserted-by":"crossref","DOI":"10.1111\/bpa.12994","article-title":"Double-edged effects of tamoxifen-in-oil-gavage on an infectious murine model for multiple sclerosis","volume":"31","author":"H\u00fclsk\u00f6tter","year":"2021","journal-title":"Brain Pathol."},{"issue":"2","key":"10.1016\/j.brainresbull.2025.111256_bib49","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1177\/1352458519858604","article-title":"Rituximab treatment for multiple sclerosis","volume":"26","author":"Ineichen","year":"2020","journal-title":"Mult. Scler. J."},{"issue":"1-2","key":"10.1016\/j.brainresbull.2025.111256_bib50","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11010-020-03703-z","article-title":"Inside(sight) of tiny communicator: exosome biogenesis, secretion, and uptake","volume":"467","author":"Jadli","year":"2020","journal-title":"Mol. Cell. Biochem."},{"issue":"11","key":"10.1016\/j.brainresbull.2025.111256_bib51","doi-asserted-by":"crossref","first-page":"8779","DOI":"10.1002\/jcp.29721","article-title":"Therapeutic effects of extracellular vesicles from human adipose-derived mesenchymal stem cells on chronic experimental autoimmune encephalomyelitis","volume":"235","author":"Jafarinia","year":"2020","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.brainresbull.2025.111256_bib52","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.biomaterials.2018.06.029","article-title":"NRP-1 targeted and cargo-loaded exosomes facilitate simultaneous imaging and therapy of glioma in vitro and in vivo","volume":"178","author":"Jia","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.brainresbull.2025.111256_bib53","first-page":"1","article-title":"Ofatumumab: a review in relapsing forms of multiple sclerosis","author":"Kang","year":"2022","journal-title":"Drugs"},{"key":"10.1016\/j.brainresbull.2025.111256_bib54","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3389\/fneur.2020.00156","article-title":"60\/30: 60% of the morbidity-associated multiple sclerosis disease burden comes from the 30% of persons with higher impairments","volume":"11","author":"Kaufmann","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.brainresbull.2025.111256_bib55","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.786111","article-title":"Stem cell-derived exosome as potential therapeutics for microbial diseases","volume":"12","author":"Keshtkar","year":"2022","journal-title":"Front. Microbiol."},{"issue":"1","key":"10.1016\/j.brainresbull.2025.111256_bib56","doi-asserted-by":"crossref","first-page":"8278","DOI":"10.1038\/s41598-019-44569-6","article-title":"Surface modification of gold nanoparticles with neuron-targeted exosome for enhanced blood\u2013brain barrier penetration","volume":"9","author":"Khongkow","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.brainresbull.2025.111256_bib57","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.nano.2017.09.011","article-title":"Engineering macrophage-derived exosomes for targeted paclitaxel delivery to pulmonary metastases: in vitro and in vivo evaluations","volume":"14","author":"Kim","year":"2018","journal-title":"Nanomed.: Nanotechnol., Biol. Med."},{"key":"10.1016\/j.brainresbull.2025.111256_bib58","doi-asserted-by":"crossref","DOI":"10.1177\/1179069518764892","article-title":"The role for exosomal microRNAs in disruption of regulatory T cell homeostasis in multiple sclerosis","volume":"12","author":"Kimura","year":"2018","journal-title":"J. Exp. Neurosci."},{"key":"10.1016\/j.brainresbull.2025.111256_bib59","doi-asserted-by":"crossref","DOI":"10.1177\/1756286419836571","article-title":"Risks and risk management in modern multiple sclerosis immunotherapeutic treatment","volume":"12","author":"Klotz","year":"2019","journal-title":"Ther. Adv. Neurol. Disord."},{"issue":"8","key":"10.1016\/j.brainresbull.2025.111256_bib60","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.3390\/pharmaceutics15082042","article-title":"Exosome-based drug delivery: translation from bench to clinic","volume":"15","author":"Koh","year":"2023","journal-title":"Pharmaceutics"},{"issue":"8","key":"10.1016\/j.brainresbull.2025.111256_bib61","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15082042","article-title":"Exosome-based drug delivery: translation from bench to clinic","volume":"15","author":"Koh","year":"2023","journal-title":"Pharmaceutics"},{"issue":"17","key":"10.1016\/j.brainresbull.2025.111256_bib62","doi-asserted-by":"crossref","first-page":"9543","DOI":"10.3390\/ijms22179543","article-title":"Exosomes engineering and their roles as therapy delivery tools, therapeutic targets, and biomarkers","volume":"22","author":"Ku\u010duk","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.brainresbull.2025.111256_bib63","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3390\/cells9020482","article-title":"T helper cells: the modulators of inflammation in multiple sclerosis","volume":"9","author":"Kunkl","year":"2020","journal-title":"Cells"},{"issue":"9","key":"10.1016\/j.brainresbull.2025.111256_bib64","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0202590","article-title":"Therapeutic potential of extracellular vesicles derived from human mesenchymal stem cells in a model of progressive multiple sclerosis","volume":"13","author":"Laso-Garc\u00eda","year":"2018","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.brainresbull.2025.111256_bib65","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s40265-023-01854-z","article-title":"Ublituximab: first approval","volume":"83","author":"Lee","year":"2023","journal-title":"Drugs"},{"key":"10.1016\/j.brainresbull.2025.111256_bib66","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.intimp.2018.12.001","article-title":"Exosomes derived from mesenchymal stem cells attenuate inflammation and demyelination of the central nervous system in EAE rats by regulating the polarization of microglia","volume":"67","author":"Li","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.brainresbull.2025.111256_bib67","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2147\/IJN.S154458","article-title":"Engineered exosome-mediated delivery of functionally active miR-26a and its enhanced suppression effect in HepG2 cells","author":"Liang","year":"2018","journal-title":"Int. J. Nanomed."},{"issue":"7","key":"10.1016\/j.brainresbull.2025.111256_bib68","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.7150\/thno.52570","article-title":"Engineering exosomes for targeted drug delivery","volume":"11","author":"Liang","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.brainresbull.2025.111256_bib69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actbio.2018.12.045","article-title":"Exosomes: the next generation of endogenous nanomaterials for advanced drug delivery and therapy","volume":"86","author":"Liao","year":"2019","journal-title":"Acta Biomater."},{"issue":"4","key":"10.1016\/j.brainresbull.2025.111256_bib70","doi-asserted-by":"crossref","DOI":"10.1002\/advs.201700611","article-title":"Exosome\u2013liposome hybrid nanoparticles deliver CRISPR\/Cas9 system in MSCs","volume":"5","author":"Lin","year":"2018","journal-title":"Adv. Sci."},{"issue":"2","key":"10.1016\/j.brainresbull.2025.111256_bib71","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/1061186X.2019.1641508","article-title":"Biological characteristics of exosomes and genetically engineered exosomes for the targeted delivery of therapeutic agents","volume":"28","author":"Lin","year":"2020","journal-title":"J. Drug Target."},{"issue":"4","key":"10.1016\/j.brainresbull.2025.111256_bib72","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.7150\/thno.30853","article-title":"Design strategies and application progress of therapeutic exosomes","volume":"9","author":"Liu","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.brainresbull.2025.111256_bib73","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.mri.2020.02.001","article-title":"Visualization of exosomes from mesenchymal stem cells in vivo by magnetic resonance imaging","volume":"68","author":"Liu","year":"2020","journal-title":"Magn. Reson. Imaging"},{"key":"10.1016\/j.brainresbull.2025.111256_bib74","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.839790","article-title":"Challenges in the development of drug delivery systems based on small extracellular vesicles for therapy of brain diseases","volume":"13","author":"Loch-Neckel","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"16","key":"10.1016\/j.brainresbull.2025.111256_bib75","doi-asserted-by":"crossref","first-page":"12912","DOI":"10.3390\/ijms241612912","article-title":"Alterations of oligodendrocyte and myelin energy metabolism in multiple sclerosis","volume":"24","author":"L\u00f3pez-Muguruza","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.brainresbull.2025.111256_bib76","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0185992","article-title":"MEX3C interacts with adaptor-related protein complex 2 and involves in miR-451a exosomal sorting","volume":"12","author":"Lu","year":"2017","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.brainresbull.2025.111256_bib77","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/aps.2017.12","article-title":"Engineering exosomes as refined biological nanoplatforms for drug delivery","volume":"38","author":"Luan","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"issue":"16","key":"10.1016\/j.brainresbull.2025.111256_bib78","doi-asserted-by":"crossref","first-page":"8946","DOI":"10.3390\/ijms22168946","article-title":"Th17-related cytokines as potential discriminatory markers between neuromyelitis optica (Devic\u2019s Disease) and multiple sclerosis\u2014a review","volume":"22","author":"Maciak","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.brainresbull.2025.111256_bib79","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/s41582-019-0240-y","article-title":"Chronic inflammation in multiple sclerosis\u2014seeing what was always there","volume":"15","author":"Matthews","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.brainresbull.2025.111256_bib80","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/B978-0-12-804279-3.00005-8","article-title":"Multiple sclerosis, and other demyelinating and autoimmune inflammatory diseases of the central nervous system","volume":"146","author":"Matute-Blanch","year":"2018","journal-title":"Handb. Clin. Neurol."},{"issue":"8","key":"10.1016\/j.brainresbull.2025.111256_bib81","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1001\/jama.2020.26858","article-title":"Diagnosis and treatment of multiple sclerosis: a review","volume":"325","author":"McGinley","year":"2021","journal-title":"Jama"},{"issue":"8","key":"10.1016\/j.brainresbull.2025.111256_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.cub.2018.01.059","article-title":"Exosomes and ectosomes in intercellular communication","volume":"28","author":"Meldolesi","year":"2018","journal-title":"Curr. Biol."},{"issue":"5","key":"10.1016\/j.brainresbull.2025.111256_bib83","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2217\/nmt-2021-0014","article-title":"An updated review of teriflunomide\u2019s use in multiple sclerosis","volume":"11","author":"Miller","year":"2021","journal-title":"Neurodegener. Dis. Manag."},{"issue":"5","key":"10.1016\/j.brainresbull.2025.111256_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2009.11.010","article-title":"Multiple sclerosis: geoepidemiology, genetics and the environment","volume":"9","author":"Milo","year":"2010","journal-title":"Autoimmun. Rev."},{"issue":"1","key":"10.1016\/j.brainresbull.2025.111256_bib85","article-title":"Current and future therapies for multiple sclerosis","volume":"2013","author":"Minagar","year":"2013","journal-title":"Scientifica"},{"issue":"9","key":"10.1016\/j.brainresbull.2025.111256_bib86","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.3390\/life12091417","article-title":"Exosomes and biomaterials: in search of a new therapeutic strategy for multiple sclerosis","volume":"12","author":"Ojeda-Hern\u00e1ndez","year":"2022","journal-title":"Life"},{"key":"10.1016\/j.brainresbull.2025.111256_bib87","first-page":"66","article-title":"Nanoparticles, liposomes and exosomes as microRNA delivery systems for neurodegenerative disease: remyelination inductors in multiple sclerosis","volume":"7","author":"Osorio-Querejeta","year":"2018","journal-title":"J. Extracell. Vesicles"},{"issue":"1-2","key":"10.1016\/j.brainresbull.2025.111256_bib88","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jneuroim.2013.10.014","article-title":"IFN\u03b3-stimulated dendritic cell exosomes as a potential therapeutic for remyelination","volume":"266","author":"Pusic","year":"2014","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.brainresbull.2025.111256_bib89","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jconrel.2018.08.035","article-title":"Dopamine-loaded blood exosomes targeted to brain for better treatment of Parkinson's disease","volume":"287","author":"Qu","year":"2018","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.brainresbull.2025.111256_bib90","doi-asserted-by":"crossref","DOI":"10.1038\/srep38743","article-title":"The secretome of periodontal ligament stem cells from MS patients protects against EAE","volume":"6","author":"Rajan","year":"2016","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.brainresbull.2025.111256_bib91","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1021\/acsabm.4c00089","article-title":"Stem cell-derived exosomes: an advanced horizon to cancer regenerative medicine","volume":"7","author":"Ramachandran","year":"2024","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.brainresbull.2025.111256_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.nano.2019.102072","article-title":"Differential in vivo biodistribution of 131I-labeled exosomes from diverse cellular origins and its implication for theranostic application","volume":"21","author":"Rashid","year":"2019","journal-title":"Nanomed.: Nanotechnol., Biol. Med."},{"issue":"21","key":"10.1016\/j.brainresbull.2025.111256_bib93","doi-asserted-by":"crossref","first-page":"4552","DOI":"10.1039\/D0TB00744G","article-title":"Surface functionalization strategies of extracellular vesicles","volume":"8","author":"Rayamajhi","year":"2020","journal-title":"J. Mater. Chem. B"},{"issue":"6","key":"10.1016\/j.brainresbull.2025.111256_bib94","doi-asserted-by":"crossref","first-page":"6670","DOI":"10.1021\/acsnano.9b01004","article-title":"Stem cell-derived exosomes as nanotherapeutics for autoimmune and neurodegenerative disorders","volume":"13","author":"Riazifar","year":"2019","journal-title":"ACS nano"},{"key":"10.1016\/j.brainresbull.2025.111256_bib95","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1146\/annurev-pathol-052920-040318","article-title":"The immune response in multiple sclerosis","volume":"17","author":"Rodr\u00edguez Mur\u00faa","year":"2022","journal-title":"Annu. Rev. Pathol.: Mech. Dis."},{"issue":"7","key":"10.1016\/j.brainresbull.2025.111256_bib96","doi-asserted-by":"crossref","first-page":"16414","DOI":"10.3390\/ijms160716414","article-title":"Alemtuzumab in multiple sclerosis: mechanism of action and beyond","volume":"16","author":"Ruck","year":"2015","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.brainresbull.2025.111256_bib97","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.3390\/biom11081131","article-title":"Transportation of single-domain antibodies through the blood\u2013brain barrier","volume":"11","author":"Ruiz-L\u00f3pez","year":"2021","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.brainresbull.2025.111256_bib98","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10787-022-01115-7","article-title":"Exosome engineering in cell therapy and drug delivery","volume":"31","author":"Sadeghi","year":"2023","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.brainresbull.2025.111256_bib99","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.jconrel.2020.07.042","article-title":"Surface functionalization of exosomes for target-specific delivery and in vivo imaging & tracking: Strategies and significance","volume":"326","author":"Salunkhe","year":"2020","journal-title":"J. Control. Release"},{"issue":"40","key":"10.1016\/j.brainresbull.2025.111256_bib100","doi-asserted-by":"crossref","first-page":"18825","DOI":"10.1039\/C9NR06183E","article-title":"Efficient encapsulation of theranostic nanoparticles in cell-derived exosomes: leveraging the exosomal biogenesis pathway to obtain hollow gold nanoparticle-hybrids","volume":"11","author":"Sancho-Albero","year":"2019","journal-title":"Nanoscale"},{"issue":"7","key":"10.1016\/j.brainresbull.2025.111256_bib101","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/glia.24148","article-title":"The roles of microglia and astrocytes in phagocytosis and myelination: insights from the cuprizone model of multiple sclerosis","volume":"70","author":"Sen","year":"2022","journal-title":"Glia"},{"key":"10.1016\/j.brainresbull.2025.111256_bib102","article-title":"Th17 cells and inflammation in neurological disorders: Possible mechanisms of action","volume":"13","author":"Shi","year":"2022","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.brainresbull.2025.111256_bib103","doi-asserted-by":"crossref","first-page":"7377","DOI":"10.1111\/ejn.15478","article-title":"Nanosystems and exosomes as future approaches in treating multiple sclerosis","volume":"54","author":"Sidoryk-W\u0119grzynowicz","year":"2021","journal-title":"Eur. J. Neurosci."},{"issue":"3","key":"10.1016\/j.brainresbull.2025.111256_bib104","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1177\/0394632017722332","article-title":"Human periodontal ligament stem cells secretome from multiple sclerosis patients suppresses NALP3 inflammasome activation in experimental autoimmune encephalomyelitis","volume":"30","author":"Soundara Rajan","year":"2017","journal-title":"Int. J. Immunopathol. Pharmacol."},{"issue":"3","key":"10.1016\/j.brainresbull.2025.111256_bib105","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1152\/physrev.00031.2018","article-title":"Myelin in the central nervous system: structure, function, and pathology","volume":"99","author":"Stadelmann","year":"2019","journal-title":"Physiol. Rev."},{"issue":"6","key":"10.1016\/j.brainresbull.2025.111256_bib106","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s40259-018-0309-y","article-title":"Emerging technologies for delivery of biotherapeutics and gene therapy across the blood\u2013brain barrier","volume":"32","author":"Stanimirovic","year":"2018","journal-title":"BioDrugs"},{"issue":"3","key":"10.1016\/j.brainresbull.2025.111256_bib107","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22031144","article-title":"Therapeutic application of exosomes in inflammatory diseases","volume":"22","author":"Suh","year":"2021","journal-title":"Int J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.brainresbull.2025.111256_bib108","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1007\/s12264-023-01034-9","article-title":"Glia connect inflammation and neurodegeneration in multiple sclerosis","volume":"39","author":"Sun","year":"2023","journal-title":"Neurosci. Bull."},{"issue":"8","key":"10.1016\/j.brainresbull.2025.111256_bib109","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24087470","article-title":"Astrocyte-derived exosomes differentially shape T cells' immune response in MS patients","volume":"24","author":"Szpakowski","year":"2023","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.brainresbull.2025.111256_bib110","first-page":"1908","article-title":"Diagnosis and treatment of MS in patients suffering from various degrees of the disease with a clinical approach: the orginal article","author":"Tahernia","year":"2022","journal-title":"J. Pharm. Negat. Results"},{"issue":"1","key":"10.1016\/j.brainresbull.2025.111256_bib111","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41392-023-01704-0","article-title":"Clinical applications of stem cell-derived exosomes","volume":"9","author":"Tan","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"9","key":"10.1016\/j.brainresbull.2025.111256_bib112","article-title":"Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis","author":"Tramacere","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"10.1016\/j.brainresbull.2025.111256_bib113","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40035-019-0178-4","article-title":"Detecting neurodegenerative pathology in multiple sclerosis before irreversible brain tissue loss sets in","volume":"8","author":"Van Schependom","year":"2019","journal-title":"Transl. Neurodegener."},{"issue":"5","key":"10.1016\/j.brainresbull.2025.111256_bib114","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.molmed.2019.02.003","article-title":"Immune cell-derived extracellular vesicles\u2013functions and therapeutic applications","volume":"25","author":"Veerman","year":"2019","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.brainresbull.2025.111256_bib115","doi-asserted-by":"crossref","first-page":"6527","DOI":"10.2147\/IJN.S388604","article-title":"Exosomes derived from immune cells: the new role of tumor immune microenvironment and tumor therapy","volume":"17","author":"Wang","year":"2022","journal-title":"Int. J. Nanomed."},{"issue":"3","key":"10.1016\/j.brainresbull.2025.111256_bib116","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1039\/D1BM01142A","article-title":"Encapsulation of bryostatin-1 by targeted exosomes enhances remyelination and neuroprotection effects in the cuprizone-induced demyelinating animal model of multiple sclerosis","volume":"10","author":"Wu","year":"2022","journal-title":"Biomater. Sci."},{"issue":"2-3","key":"10.1016\/j.brainresbull.2025.111256_bib117","first-page":"61","article-title":"Drug loading techniques for exosome-based drug delivery systems","volume":"76","author":"Xi","year":"2021","journal-title":"Die Pharm. - Int. J. Pharm. Sci."},{"issue":"18","key":"10.1016\/j.brainresbull.2025.111256_bib118","doi-asserted-by":"crossref","first-page":"8926","DOI":"10.7150\/thno.62330","article-title":"Engineered exosomes: desirable target-tracking characteristics for cerebrovascular and neurodegenerative disease therapies","volume":"11","author":"Xu","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.brainresbull.2025.111256_bib119","article-title":"The biogenesis and secretion of exosomes and multivesicular bodies (MVBs): Intercellular shuttles and implications in human diseases","author":"Xu","year":"2022","journal-title":"Genes Dis."},{"key":"10.1016\/j.brainresbull.2025.111256_bib120","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.omto.2021.12.005","article-title":"Nucleic acids and proteins carried by exosomes of different origins as potential biomarkers for gynecologic cancers","volume":"24","author":"Ye","year":"2022","journal-title":"Mol. Ther. -Oncolytics"},{"issue":"9","key":"10.1016\/j.brainresbull.2025.111256_bib121","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1002\/eji.201243295","article-title":"Exosomes with membrane-associated TGF-\u03b21 from gene-modified dendritic cells inhibit murine EAE independently of MHC restriction","volume":"43","author":"Yu","year":"2013","journal-title":"Eur. J. Immunol."},{"issue":"4","key":"10.1016\/j.brainresbull.2025.111256_bib122","first-page":"105","article-title":"Mechanism and adverse effects of multiple sclerosis drugs: a review article. Part 2","volume":"11","author":"Zadeh","year":"2019","journal-title":"Int. J. Physiol., Pathophysiol. Pharmacol."},{"issue":"10","key":"10.1016\/j.brainresbull.2025.111256_bib123","doi-asserted-by":"crossref","DOI":"10.3390\/cells12101416","article-title":"Current strategies for exosome cargo loading and targeting delivery","volume":"12","author":"Zeng","year":"2023","journal-title":"Cells"},{"issue":"11","key":"10.1016\/j.brainresbull.2025.111256_bib124","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202203391","article-title":"Engineering of M2 macrophages-derived exosomes via click chemistry for spinal cord injury repair","volume":"12","author":"Zeng","year":"2023","journal-title":"Adv. Healthc. Mater."},{"issue":"19","key":"10.1016\/j.brainresbull.2025.111256_bib125","doi-asserted-by":"crossref","first-page":"5707","DOI":"10.1039\/D2BM00518B","article-title":"High-efficiency brain-targeted intranasal delivery of BDNF mediated by engineered exosomes to promote remyelination","volume":"10","author":"Zhai","year":"2022","journal-title":"Biomater. Sci."},{"issue":"8","key":"10.1016\/j.brainresbull.2025.111256_bib126","article-title":"NSCs migration promoted and drug delivered exosomes-collagen scaffold via a bio-specific peptide for one-step spinal cord injury repair","volume":"10","author":"Zhang","year":"2021","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.brainresbull.2025.111256_bib127","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2147\/JIR.S421649","article-title":"Immune cell-derived exosomes in inflammatory disease and inflammatory tumor microenvironment: a review","author":"Zhang","year":"2024","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.brainresbull.2025.111256_bib128","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jconrel.2022.12.026","article-title":"Resveratrol-loaded macrophage exosomes alleviate multiple sclerosis through targeting microglia","volume":"353","author":"Zheng","year":"2023","journal-title":"J. Control. Release: Off. J. Control. Release Soc."},{"issue":"1","key":"10.1016\/j.brainresbull.2025.111256_bib129","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13287-023-03345-0","article-title":"Stem cell-derived exosomes: emerging therapeutic opportunities for wound healing","volume":"14","author":"Zhou","year":"2023","journal-title":"Stem Cell Res. Ther."}],"container-title":["Brain Research Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923025000681?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923025000681?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T16:27:52Z","timestamp":1778689672000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0361923025000681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":129,"alternative-id":["S0361923025000681"],"URL":"https:\/\/doi.org\/10.1016\/j.brainresbull.2025.111256","relation":{},"ISSN":["0361-9230"],"issn-type":[{"value":"0361-9230","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exosome-based platforms for treatment of multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Brain Research Bulletin","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainresbull.2025.111256","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111256"}}